Search

Your search keyword '"Akpek EK"' showing total 192 results

Search Constraints

Start Over You searched for: Author "Akpek EK" Remove constraint Author: "Akpek EK"
192 results on '"Akpek EK"'

Search Results

1. Glaucoma and Ocular Surface Disease: More than Meets the Eye

3. TFOS DEWS II Introduction

5. Clinical Review:Topical Ophthalmic Use of Cyclosporin A

6. Topical ciclosporin in the treatment of ocular surface disorders

7. Long-term immunosuppressive treatment of serpiginous choroiditis

8. Limbal stem-cell transplantation

12. Clinical features and prognosis of Boston type I keratoprosthesis-associated corneal melt

14. Demographic and Psychiatric Associations With Dry Eye in a Medicare Population.

15. Pooled results from two pivotal randomized controlled clinical trials: ESSENCE-1 and ESSENCE-2 to assess efficacy and safety of a water-free ciclosporin 0.1% formulation for the treatment of dry eye disease.

17. Development and Validation of Claims-Based Algorithms for Conjunctivitis and Keratitis.

18. The evolution of cyclosporine treatments for treatment of ocular surface diseases.

19. Dexamethasone Intracanalicular Insert for Clinically Significant Aqueous-Deficient Dry Eye: A Randomized Controlled Trial.

20. Enhancing online cataract surgery patient education materials through artificial intelligence.

21. Cornea Classic: Bron, Evans, and Smith, "Grading of Corneal and Conjunctival Staining in the Context of Other Dry Eye Tests" (2003).

22. Ten-Year Outcome of Boston Type I Keratoprosthesis Surgery at a Tertiary Care Center.

23. Efficacy of a new water-free topical cyclosporine 0.1% solution for optimizing the ocular surface in patients with dry eye and cataract.

24. Design and Biocompatibility of a Novel, Flexible Artificial Cornea.

25. The Sjögren's Working Group: The 2023 OMERACT meeting and provisional domain generation.

26. Usability of Patient Education-Oriented Cataract Surgery Websites.

27. United States Regulatory Approval of Topical Treatments for Dry Eye.

28. Sjögren's Versus Non-Sjögren's Ocular Features: Similar Symptoms, But Significantly Worse Signs.

29. Long-term outcomes of therapeutic corneal transplants performed in a tertiary eye care hospital in South India.

30. Twelve-Month Clinical and Histopathological Performance of a Novel Synthetic Cornea Device in Rabbit Model.

31. Prospective, Randomized, Multicenter, Double-Masked, Clinical Trial of Corneal Cross-Linking for Boston Keratoprosthesis Carrier Tissue.

32. Efficacy and Safety of a Water-Free Topical Cyclosporine, 0.1%, Solution for the Treatment of Moderate to Severe Dry Eye Disease: The ESSENCE-2 Randomized Clinical Trial.

33. Symptom-Based Cluster Analysis Categorizes Sjögren's Disease Subtypes: An International Cohort Study Highlighting Disease Severity and Treatment Discordance.

34. Antibodies to Both Ro52 and Ro60 for Identifying Sjögren's Syndrome Patients Best Suited for Clinical Trials of Disease-Modifying Therapies.

35. Reduced tear thrombospondin-1/matrix metalloproteinase-9 ratio can aid in detecting Sjögren's syndrome etiology in patients with dry eye.

36. Trends in Early Graft Failure Leading to Regrafting After Endothelial Keratoplasty in the United States.

37. A comprehensive overview of living with Sjögren's: results of a National Sjögren's Foundation survey.

38. Associations Between Smoking and Primary Sjögren Syndrome Classification Using the Sjögren's International Collaborative Clinical Alliance Cohort.

39. Reliability of Several Glaucoma Tests in Patients With Boston Type 1 Keratoprosthesis.

40. Outcome Measures to Assess Dry Eye Severity: A Review.

41. Surgeon Preference for Keratoplasty Techniques and Barriers to Performing Deep Anterior Lamellar Keratoplasty.

42. Impact of COVID-19 Pandemic on Infectious Keratitis Outcomes: A Retrospective Multicenter Study in Tertiary Eye Hospitals of South India.

43. Autologous serum eye drops for ocular surface disorders.

44. Impact of the COVID-19 pandemic on eye strain and dry eye symptoms.

45. National Sjögren's Foundation Survey: Burden of Oral and Systemic Involvement on Quality of Life.

46. Neuropathic Pain in the Eyes, Body, and Mouth: Insights from the Sjögren's International Collaborative Clinical Alliance.

47. A New Screening Questionnaire to Identify Patients With Dry Eye With a High Likelihood of Having Sjögren Syndrome.

48. Cicatrizing conjunctivitis as an uncommon manifestation of primary Sjögren's syndrome.

49. Ocular Manifestations and Burden Related to Sjögren Syndrome: Results of a Patient Survey.

Catalog

Books, media, physical & digital resources